| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/08/2007 | EP1814849A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/08/2007 | EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 08/08/2007 | EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/08/2007 | CN1330644C Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 08/08/2007 | CN1330633C Pyrrolidine derivatives as oxytocin antagonists |
| 08/08/2007 | CN101014589A Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 08/08/2007 | CN101014588A Pyrrole derivatives, their preparation and their therapeutic use |
| 08/08/2007 | CN101014565A Diarylsulfones as 5-HT2a antagonists |
| 08/08/2007 | CN101012211A Substituted andrographolide derivative, preparing method and pharmaceutical compound thereof |
| 08/08/2007 | CN101012193A Novel CB 1 receptour inverse agonists |
| 08/08/2007 | CN101012192A Method of preparing zofenopril calcium |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253207 Quinones as disease therapies |
| 08/07/2007 | US7253205 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 08/07/2007 | US7253204 Antiproliferative agents |
| 08/07/2007 | US7253198 Hydroxyethylamine derivatives for the treatment of Alzheimer's disease |
| 08/07/2007 | US7253185 Amino ceramide-like compounds and therapeutic methods of use |
| 08/07/2007 | US7253182 Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
| 08/07/2007 | US7253180 Viricides; immunology moderator |
| 08/07/2007 | US7253138 quaternary ammoniumalkyl- derivatives (especially betaines) of succinimides prepared from succinic anhydrides and di-substituted aminoalkylamines; for use in equipment for extracting and transporting hydrocarbons in crude oil extraction and processing. |
| 08/07/2007 | US7253007 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 08/07/2007 | US7252895 Phosphorescence compound and electro field light emitting device having the same |
| 08/07/2007 | CA2221689C Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 08/07/2007 | CA2210973C Method of preparing retroviral protease inhibitor intermediates |
| 08/07/2007 | CA2207804C Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 08/02/2007 | WO2007085858A1 Method of extracting domoic acid by selective adsorption using a halogenated carboxylic acid derivative |
| 08/02/2007 | WO2007085718A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof |
| 08/02/2007 | WO2007085042A1 Novel lactams |
| 08/02/2007 | WO2007070760A3 Compounds which modulate the cb2 receptor |
| 08/02/2007 | WO2007070667A3 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 08/02/2007 | WO2007060220A3 Cyanobenzene compounds for combating animal pests |
| 08/02/2007 | US20070179315 of aromatic groups using transition metal catalysis in compressed carbon dioxide; intermediates |
| 08/02/2007 | US20070179308 Process for preparing amophous (4r-cis)-6-[2-[3-phenyl-4-(Phenylcarbamoyl)-2-4-Fluorophenyl)-5-(1-Methylethyl)-Pyrrol-1-YL]-Ethyl]-2,2-Dimethyl-[1,3]-Dioxane-4-YL-Acetic Acid |
| 08/02/2007 | US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/02/2007 | US20070179098 Use of asimadoline hydrochloride |
| 08/02/2007 | DE102006048300A1 Inhibitoren des Blutgerinnungsfaktors Xa zur Verwendung als Antikoagulans Inhibitors of coagulation factor Xa for use as an anticoagulant |
| 08/02/2007 | CA2637287A1 Novel lactams |
| 08/02/2007 | CA2627607A1 Fap inhibitors |
| 08/01/2007 | EP1812443A2 [3.2.0] heterocyclic compounds and methods of using the same |
| 08/01/2007 | EP1812425A2 C-fms kinase inhibitors |
| 08/01/2007 | EP1812008A1 Il-8 receptor antagonists |
| 08/01/2007 | EP1811841A2 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives |
| 08/01/2007 | EP1560811B1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 08/01/2007 | EP1534704B1 Process for preparing 5-(4-fluorophenyl)-1-¬2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl|-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | CN1329375C Novel anti-diabetic agents |
| 08/01/2007 | CN1329374C Compound as CCR5 agonist |
| 08/01/2007 | CN101010324A Method for preparing pyrrolotriazine compounds |
| 08/01/2007 | CN101010281A Alternative synthesis of renin inhibitors and intermediates thereof |
| 08/01/2007 | CN101007805A 6-cyano-1,1-disubstituted alkoxy(alkylsulphide)-7-[(carbalkoxy)-methyl]-5-oxo-delta6(8)-tetrahydro indolizine compound preparation method |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007800A Compound for preparing nifeviroc and its preparing process |
| 08/01/2007 | CN101007778A Chain-prolonged type fluorenyl bimaleimide and its preparation method |
| 08/01/2007 | CN101007777A (s)-(-)-5-tributyltin-N-[(1-allyl-2-pyrrolidinyl)methyl]-2,3-dimethoxybenzamide preparation method |
| 07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
| 07/31/2007 | US7250521 Method for production of Δ1-pyrrolines |
| 07/31/2007 | US7250520 Processes for preparing pyrroles |
| 07/31/2007 | US7250444 Pyrrole-based HMG-CoA reductase inhibitors |
| 07/31/2007 | US7250414 Antihistamines; bronchodilator agents; respiratory system disorders; 2-{(S)-1-[4-(4-aminophenyl)butyl]pyrrolidin-3-yl}-2,2-diphenylacetamide; chemical synthesis; Bioassay of testing the compound on the biological sample |
| 07/31/2007 | US7250409 Ningalin B analogs employable for reversing multidrug resistance |
| 07/31/2007 | CA2333603C New dipeptidyl peptidase iv effectors |
| 07/31/2007 | CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/31/2007 | CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/26/2007 | WO2007058971A3 Soft anticholinergic esters |
| 07/26/2007 | WO2007057703A3 Intermediate compounds for the preparation of statins |
| 07/26/2007 | US20070173643 Process for Producing Cyclic Compounds |
| 07/26/2007 | US20070173498 Melanin concentrating hormone antagonist |
| 07/26/2007 | US20070172951 Time-temperature indicator based on valence isomerizations |
| 07/26/2007 | US20070172849 Detection of markers in nascent proteins |
| 07/26/2007 | US20070172421 Substituted pyrrolidine-2-ones |
| 07/25/2007 | EP1809635A1 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives |
| 07/25/2007 | EP1809634A1 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 07/25/2007 | EP1809600A2 Cyclic b-amino acid derivatives as factor xa inhibitors |
| 07/25/2007 | EP1809597A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/25/2007 | EP1809275A1 Chemical compounds |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2007 | CN1327766C Compounds, compositions, and methods for controlling biofilms |
| 07/25/2007 | CN101006052A Pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | CN101005835A 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diab |
| 07/24/2007 | USRE39744 Adamantane derivatives and process for producing them |
| 07/24/2007 | US7247756 1,4-disubstituted benzenes as insecticides |
| 07/24/2007 | US7247748 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and reverse cholesterol transport |
| 07/24/2007 | US7247740 Reacting perfluoroalkanesulfonic acid directly with dialkyl carbonate to give alkyl perfluoroalkanesulfonate optionally in the presence of a water or alcohol consuming reagent, and preparing an alkyl perfluoroalkanesulfonate with an alkylamine or alkylphosphine to prepare perfluoroalkanesulfonic acid |
| 07/19/2007 | WO2007080470A2 A method for the purification of levetiracetam |
| 07/19/2007 | WO2007079958A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments |
| 07/19/2007 | WO2007064931A3 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 07/19/2007 | WO2007054225A3 Pyroglutamic acid esters with improved biodegradability |
| 07/19/2007 | WO2007035722A3 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 07/19/2007 | WO2007015824A3 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 07/19/2007 | WO2006138660A3 Sphingosine kinase inhibitors |
| 07/19/2007 | WO2006131304A3 Process for preparing renin inhibitors |
| 07/19/2007 | US20070167644 Bifunctional energy-reversible acyl-compositions |
| 07/19/2007 | US20070167512 Lipid metabolism improving agent |
| 07/19/2007 | US20070167501 Bicyclo derivative |
| 07/19/2007 | US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 07/19/2007 | US20070167486 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring |
| 07/19/2007 | US20070167452 Therapeutic amide derivatives |
| 07/19/2007 | US20070167440 Novel pyrrolidine compound and a process for preparing the same |
| 07/19/2007 | US20070166276 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |